FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between MOS Utility IPO and Sotac Pharmaceuticals IPO.
MOS Utility IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Sotac Pharmaceuticals IPO is a SME Book Built Issue proposed to list at NSE SME.
MOS Utility IPO | Sotac Pharmaceuticals IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Unistone Capital Pvt Ltd | Beeline Capital Advisors Pvt Ltd |
Registrar | Skyline Financial Services Private Ltd | Kfin Technologies Limited |
Market Maker | Rikhav Securities Limited | Sunflower Broking Private Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of MOS Utility IPO is up to ₹49.97 Cr whereas the issue size of the Sotac Pharmaceuticals IPO is up to ₹33.30 Cr. The final issue price of MOS Utility IPO is ₹76.00 per share and of Sotac Pharmaceuticals IPO is ₹111.00 per share.
MOS Utility IPO | Sotac Pharmaceuticals IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹72.00 per share | ₹105.00 per share |
Issue Price (Upper) | ₹76.00 per share | ₹111.00 per share |
Issue Price (Final) | ₹76.00 per share | ₹111.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1600 shares | 1200 shares |
Fresh Issue Size | 57,74,400 shares | 30,00,000 shares |
Fresh Issue Size (Amount) | up to ₹43.89 Cr | up to ₹33.30 Cr |
OFS Issue Size | 8,00,000 shares | |
OFS Issue Size (Amount) | up to ₹6.08 Cr | |
Issue Size Total | 65,74,400 shares | 30,00,000 shares |
Issue Size Total (Amount) | up to ₹49.97 Cr | up to ₹33.30 Cr |
MOS Utility IPO opens on Mar 31, 2023, while Sotac Pharmaceuticals IPO opens on Mar 29, 2023. The closing date of MOS Utility IPO and Sotac Pharmaceuticals IPO is Apr 06, 2023, and Apr 03, 2023, respectively.
MOS Utility IPO | Sotac Pharmaceuticals IPO | |
---|---|---|
Anchor Bid Date | Mar 29, 2023 | Mar 28, 2023 |
Issue Open | Mar 31, 2023 | Mar 29, 2023 |
Issue Close | Apr 06, 2023 | Apr 03, 2023 |
Basis Of Allotment (Tentative) | Apr 12, 2023 | Apr 10, 2023 |
Initiation of Refunds (Tentative) | Apr 13, 2023 | Apr 11, 2023 |
Credit of Share (Tentative) | Apr 17, 2023 | Apr 12, 2023 |
Listing date (Tentative) | Apr 18, 2023 | Apr 13, 2023 |
Anchor Lockin End date 1 | May 12, 2023 | May 10, 2023 |
Anchor Lockin End date 2 | Jul 11, 2023 | Jul 09, 2023 |
MOS Utility IPO P/E ratio is 48.41, as compared to Sotac Pharmaceuticals IPO P/E ratio of 132.14.
MOS Utility IPO | Sotac Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 82.91% | 84.63% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 48.41 | 132.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹189.51 Cr. | ₹122.66 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 14.06%% | 6.38%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 11.26%% | 19.03%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.45 | 2.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the MOS Utility IPO retail investors (RII) are offered 21,85,600 shares while in Sotac Pharmaceuticals IPO retail investors are offered 21,85,600 shares. Qualified institutional buyers (QIB) are offered 15,23,200 shares in MOS Utility IPO and 5,71,800 shares in Sotac Pharmaceuticals IPO.
MOS Utility IPO | Sotac Pharmaceuticals IPO | |
---|---|---|
Anchor Investor Reserveration | 15,98,400 shares | 8,53,200 shares |
Market Maker Reserveration | 3,29,600 shares | 1,50,000 shares |
QIB | 15,23,200 shares | 5,71,800 shares |
NII | 9,37,600 shares | 4,28,400 shares |
RII | 21,85,600 shares | 9,98,400 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 46,46,400 shares | 19,98,600 shares |
MOS Utility IPO subscribed 21.14x in total, whereas Sotac Pharmaceuticals IPO subscribed 1.60x.
MOS Utility IPO | Sotac Pharmaceuticals IPO | |
---|---|---|
QIB (times) | 11.67x | 1.00x |
NII (times) | 57.90x | 4.04x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 11.98x | 0.91x |
Employee (times) | ||
Other (times) | ||
Total (times) | 21.14x | 1.60x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|